S

Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250

Watchlist Manager
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Watchlist
Price: 104 000 KRW -0.76% Market Closed
Market Cap: 2.4T KRW
Have any thoughts about
Sam Chun Dang Pharm Co Ltd?
Write Note

Gross Margin
Sam Chun Dang Pharm Co Ltd

47.4%
Current
50%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
47.4%
=
Gross Profit
98.7B
/
Revenue
208.2B

Gross Margin Across Competitors

Country KR
Market Cap 2.4T KRW
Gross Margin
47%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 744.2B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 373.9B USD
Gross Margin
69%
Country US
Market Cap 258.4B USD
Gross Margin
77%
Country CH
Market Cap 200.6B CHF
Gross Margin
73%
Country UK
Market Cap 161.8B GBP
Gross Margin
82%
Country CH
Market Cap 180.7B CHF
Gross Margin
75%
Country US
Market Cap 146.9B USD
Gross Margin
71%
No Stocks Found

Sam Chun Dang Pharm Co Ltd
Glance View

Market Cap
2.4T KRW
Industry
Pharmaceuticals

SAM CHUN DANG PHARM Co., Ltd. engages in the manufacture of pharmaceuticals. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2000-10-04. CO., LTD is a Korea-based company mainly engaged in the manufacture of prescription medicines. The Company’s products portfolio consists of antibiotics used for treatment of sepsis, respiratory diseases and others; circulatory disease medicines including cardiovascular and endocrine medicaments used for treatment of diabetes, hypertension, angina and others under the brand names of Glilazide and Atenolol; digestive medicines used for treatment of duodenal ulcer, gastritis and others; ophthalmological agents used for treatment of conjunctivitis, keratitis and other eye inflammation under the brand names of Ofus and Toracin, and anti-inflammatories used to release postoperative pains under the brand name Barotase and others.

Intrinsic Value
11 241.66 KRW
Overvaluation 89%
Intrinsic Value
Price
S

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
47.4%
=
Gross Profit
98.7B
/
Revenue
208.2B
What is the Gross Margin of Sam Chun Dang Pharm Co Ltd?

Based on Sam Chun Dang Pharm Co Ltd's most recent financial statements, the company has Gross Margin of 47.4%.